Zhejiang Jolly Pharmaceutical Co Ltd (300181) — Cash Flow Reinvestment Rate
Zhejiang Jolly Pharmaceutical Co Ltd (300181) has a Cash Flow Reinvestment Rate of 0.15x as of June 2025, reinvesting CN¥56.30 Million (capex CN¥19.94 Million plus investments CN¥-36.36 Million) from operating cash flow of CN¥367.02 Million. Explore how much does Zhejiang Jolly Pharmaceutical Co Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Jolly Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Zhejiang Jolly Pharmaceutical Co Ltd across 19 annual periods. Also explore Zhejiang Jolly Pharmaceutical Co Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Zhejiang Jolly Pharmaceutical Co Ltd (2007–2025)
Year-by-year capital reinvestment analysis for Zhejiang Jolly Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 300181 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | CN¥412.14 Million | CN¥411.80 Million | CN¥287.14 Million | ▼ -28.3% |
| 2024 | 1.40x | CN¥414.53 Million | CN¥297.05 Million | CN¥262.89 Million | ▲ +1.8% |
| 2023 | 1.37x | CN¥395.29 Million | CN¥288.46 Million | CN¥131.71 Million | ▲ +88.0% |
| 2022 | 0.73x | CN¥232.28 Million | CN¥318.59 Million | CN¥178.03 Million | ▼ -26.9% |
| 2021 | 1.00x | CN¥251.15 Million | CN¥251.80 Million | CN¥147.95 Million | ▲ +116.1% |
| 2020 | 0.46x | CN¥129.08 Million | CN¥279.69 Million | CN¥58.35 Million | ▼ -25.8% |
| 2019 | 0.62x | CN¥80.22 Million | CN¥128.94 Million | CN¥40.46 Million | ▼ -83.0% |
| 2018 | 3.66x | CN¥286.30 Million | CN¥78.28 Million | CN¥153.92 Million | ▼ -84.3% |
| 2017 | 23.26x | CN¥151.37 Million | CN¥6.51 Million | CN¥124.40 Million | ▲ +266.4% |
| 2016 | 6.35x | CN¥370.19 Million | CN¥58.30 Million | CN¥143.24 Million | ▲ +132.5% |
| 2015 | 2.73x | CN¥265.21 Million | CN¥97.13 Million | CN¥26.08 Million | ▼ -4.8% |
| 2014 | 2.87x | CN¥39.30 Million | CN¥13.70 Million | CN¥39.30 Million | ▲ +256.8% |
| 2013 | 0.80x | CN¥23.73 Million | CN¥29.50 Million | CN¥23.73 Million | ▼ -33.8% |
| 2012 | 1.21x | CN¥37.05 Million | CN¥30.51 Million | CN¥37.05 Million | ▼ -73.0% |
| 2011 | 4.49x | CN¥61.32 Million | CN¥13.65 Million | CN¥61.32 Million | ▲ +652.1% |
| 2010 | 0.60x | CN¥38.68 Million | CN¥64.78 Million | CN¥38.68 Million | ▲ +33.7% |
| 2009 | 0.45x | CN¥19.60 Million | CN¥43.89 Million | CN¥19.60 Million | ▲ +11.3% |
| 2008 | 0.40x | CN¥12.50 Million | CN¥31.16 Million | CN¥12.50 Million | ▼ -29.4% |
| 2007 | 0.57x | CN¥9.12 Million | CN¥16.05 Million | CN¥9.12 Million | — |